Historique de carrière de Philip Roberts
Anciens postes connus de Philip Roberts
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMMUNOME, INC. | Chief Tech/Sci/R&D Officer | 01/01/2023 | 01/01/2024 |
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 01/01/2019 | 01/11/2022 |
Formation de Philip Roberts
| Louisiana State University | Graduate Degree |
| Rensselaer Polytechnic Institute | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Philip Roberts
- Expérience
